Targets in allergy-directed immunotherapy.

Verhagen J; Taylor A; Akdis M; Akdis CA

doi:10.1517/14728222.9.2.217

Back

Journal article

Targets in allergy-directed immunotherapy.

Verhagen J Swiss Institute of Allergy and Asthma Research, CH-7270 Davos, Switzerland.
Taylor A
Akdis M
Akdis CA

2005-06-07

Published in:

Expert opinion on therapeutic targets. - 2005

English Allergic diseases such as asthma, atopic dermatitis, rhinitis and urticaria are immunological disorders affecting almost one third of the population in industrialised countries. Therapeutic or prophylactic approaches to turn around the increasing prevalence of these diseases have been intensively investigated. Allergen-specific immunotherapy has been applied in clinical practice for many decades, although varying results and occasional severe side effects have called for more effective and safer vaccines. Recent advances in our knowledge of immunological mechanisms have created several options to comply with these demands. This article will focus on some of the most promising new developments.

Language